Centrus Energy (LEU) ships first new centrifuge to Ohio, but commercial uranium enrichment remains a 2029 test

Centrus Energy Corp. (NYSE: LEU) has begun shipping newly manufactured centrifuges from Tennessee to Ohio, marking a manufacturing milestone in its multibillion-dollar expansion of domestic uranium enrichment capacity. The October 29, 2026 announcement confirmed that the first new centrifuge had been completed at the company’s Oak Ridge facility ahead of its year-end target and was being shipped to Ohio for final assembly. The achievement follows a $560 million manufacturing investment, a $900 million US Department of Energy enrichment contract and the recent acquisition of a critical equipment supplier. It provides tangible evidence that Centrus Energy is advancing beyond expansion planning towards industrial production of the equipment required to increase uranium enrichment capacity. However, the new enrichment capacity is not expected to enter service until 2029, leaving a substantial interval between manufacturing progress and the generation of additional commercial enrichment output.

The milestone comes at a time when the United States is seeking to reduce reliance on foreign nuclear fuel enrichment, particularly supplies historically sourced from Russia. Centrus Energy is developing capacity for conventional low-enriched uranium used by operating nuclear reactors and high-assay low-enriched uranium, or HALEU, required by several advanced reactor designs. Its expansion also has a national security dimension because the company says its domestically manufactured centrifuges can support enrichment requirements that depend on an unobligated American supply chain.

Centrus Energy said the latest development also confirmed that it had assembled a complete domestic manufacturing supply network for its centrifuge programme. The next challenge involves increasing production rates, installing additional centrifuge cascades and completing the infrastructure needed to turn equipment manufacturing into sustained uranium enrichment operations.

Why the first centrifuge shipment changes Centrus Energy’s Ohio expansion from planning to manufacturing execution

The October announcement represents the first delivery milestone in a manufacturing programme restarted in December 2025. Centrus Energy began producing new centrifuges at Oak Ridge to support expanded operations at its existing enrichment facility in Piketon, Ohio. The company subsequently announced a $560 million investment in January 2026 to modernise and expand its Oak Ridge Technology and Manufacturing Center.

The programme is designed to establish production capacity for thousands of advanced centrifuges. Centrus Energy has already been manufacturing individual components and increasing throughput while contracting a network of domestic suppliers. Completing the first new machine demonstrates that the manufacturing process has progressed from component production to the assembly of finished equipment.

The achievement also arrived ahead of management’s previously stated deadline of December 2026. Chief executive officer Amir Vexler characterised the development as evidence that the business was translating investment into physical manufacturing capabilities. He also emphasised the specialised engineering and manufacturing requirements involved in restoring domestic enrichment capacity at industrial scale.

The next stage is more demanding than producing an initial machine. Centrifuges must be manufactured consistently, transported, assembled into cascades and integrated with the supporting equipment required for enrichment operations. A successful first unit provides evidence of manufacturing progress but does not establish the throughput, cost efficiency or operating reliability of a substantially expanded production network.

Centrus Energy has not disclosed the number of newly manufactured centrifuges expected to be installed during the initial expansion phase or an updated annual production rate for the Oak Ridge factory. The absence of those figures limits the ability to translate the milestone directly into future enrichment capacity.

How the $560 million Oak Ridge investment connects with the planned 2029 enrichment expansion

The company’s manufacturing strategy separates equipment production from uranium enrichment operations. Oak Ridge serves as the manufacturing centre for advanced centrifuges, while Piketon is the location where additional enrichment capacity will be installed and operated.

Centrus Energy intends to use newly produced centrifuges to establish additional cascades capable of manufacturing both conventional low-enriched uranium and HALEU. The initial expansion is scheduled to bring new capacity online in 2029, subject to the completion of construction, equipment installation, commissioning and other required activities.

This timetable means the latest announcement advances one component of a multiyear programme rather than immediately increasing the volume of enriched uranium available for sale. Manufacturing capacity for centrifuges and operating enrichment capacity are separate measures of industrial progress. A factory capable of producing more machines can support expansion, but commercial enrichment requires the full facility to be installed, qualified and operating reliably.

Centrus Energy’s existing cascade in Ohio has already been producing HALEU since late 2023. The company said its technology has accumulated more than four million machine-hours of successful operation, with some components manufactured in 2019 and others originating from earlier production periods.

That operating history reduces uncertainty surrounding the underlying centrifuge technology compared with a completely untested enrichment system. However, the challenge now involves scaling production and installation across a much larger industrial programme. Reproducing proven equipment at higher manufacturing rates still requires consistent component quality, supplier coordination and production-line reliability.

The project’s economics will also depend on the relationship between manufacturing expenditure and future enrichment contracts. Commissioning capacity ahead of sufficient commercial demand could increase capital requirements without immediately producing corresponding revenue. Conversely, a successful expansion supported by long-term customer commitments could improve the visibility of future enrichment sales.

The $116 million Westerman acquisition strengthens a critical centrifuge manufacturing supply chain

Centrus Energy’s October 16 acquisition of Westerman Holdings, LLC adds another operational element to the expansion. The transaction, announced publicly on October 19, was valued at approximately $116 million, comprising $95 million in cash and $21 million in Centrus Energy equity.

Westerman manufactures centrifuge casings and other major components used in the American Centrifuge programme. By acquiring the supplier, Centrus Energy has brought an established manufacturing capability under direct ownership while expanding its exposure to adjacent industrial markets.

The acquisition can strengthen supply-chain coordination by reducing dependence on a separate commercial supplier for selected components. Direct ownership may also improve visibility over manufacturing schedules, equipment investment and quality-control processes as Centrus Energy increases centrifuge production.

However, ownership of a supplier does not remove all industrial execution requirements. Westerman’s facilities must continue supporting existing commercial activities while meeting the expanding demands of the nuclear programme. Integration expenses, production investment and the allocation of manufacturing capacity will influence the eventual financial benefits.

Management expects the acquisition to be accretive to adjusted earnings per share during the first year after closing. That remains a company expectation rather than a realised financial result. The transaction’s operating contribution will become clearer when Centrus Energy reports consolidated performance incorporating the acquired business.

The purchase also provides potential diversification because Westerman serves customers in industrial markets beyond nuclear enrichment. Those activities could broaden Centrus Energy’s manufacturing revenue base, although the company has not disclosed sufficient forward financial information to quantify their future contribution.

Why the $900 million US Department of Energy contract is strategically important but not immediate revenue

Centrus Energy’s expansion is supported by a $900 million task order awarded through the US Department of Energy’s HALEU production programme. The company formalised the agreement in July 2026, establishing a contractual framework for deploying commercial-scale enrichment capacity and delivering specified quantities of HALEU.

The contract is structured around performance milestones rather than an unconditional immediate payment of the entire award. The Department of Energy is expected to provide funding as Centrus Energy meets the relevant contractual requirements.

The agreement also includes options valued at up to an additional $170 million for specified future HALEU deliveries. These optional amounts should not be treated as assured revenue because the government retains discretion over whether to exercise the relevant provisions.

The programme forms part of broader federal efforts to develop domestic enriched uranium supplies for existing nuclear reactors and emerging advanced reactor technologies. In January 2026, the Department of Energy announced three task orders worth $900 million each, including awards to American Centrifuge Operating, LLC, the Centrus Energy subsidiary, and General Matter for HALEU capacity development.

The commercial structure creates a relationship between government-supported infrastructure construction and future enrichment services. Federal funding can reduce the amount of private capital required for specified activities, but the economics still depend on meeting contractual milestones and establishing commercially sustainable operations.

Centrus Energy’s expansion also includes conventional low-enriched uranium capacity intended to serve operating reactors. That part of the business addresses a broader existing fuel market than the emerging HALEU segment, where demand depends partly on the commercial deployment of advanced nuclear technologies.

The distinction between the two products is commercially important. Conventional low-enriched uranium serves a large installed reactor fleet, while HALEU demand is connected more closely to the future development schedules of advanced reactors. Combining these markets could diversify customer opportunities, but the timing and certainty of demand differ.

Can Centrus Energy benefit from America’s efforts to replace Russian nuclear fuel supplies?

The United States has historically depended on international enrichment capacity to supply its commercial nuclear reactor fleet. Russian enrichment services have represented a material portion of US fuel requirements, making supply diversification an important issue for utilities and federal policymakers.

The Prohibiting Russian Uranium Imports Act introduced restrictions on Russian low-enriched uranium imports beginning in August 2024, with a statutory prohibition extending through 2040. The framework includes limited waiver provisions for specified circumstances, meaning the transition away from Russian supplies is governed by both statutory restrictions and implementation arrangements.

The policy has increased the strategic importance of domestic enrichment investments. Centrus Energy’s expansion is intended to provide an American source of enrichment services capable of supporting commercial customers and national security requirements.

Its supply-chain approach is also relevant to the origin of enrichment equipment. Centrus Energy says it has established a complete domestic, unobligated manufacturing network, including suppliers capable of producing specialised centrifuge components.

This could be valuable for customers and government programmes requiring assurance over manufacturing provenance and supply access. However, the company has not disclosed detailed cost comparisons between its planned domestic enrichment operations and established international competitors.

Domestic production can improve supply security without necessarily providing the lowest unit cost. Competitive pricing will depend on equipment utilisation, electricity costs, financing expenditure, operating performance and long-term enrichment contracts.

The United States is also supporting other enrichment developers, including companies pursuing different technologies and expansion strategies. Centrus Energy’s established operating history provides a relevant capability advantage, but it does not guarantee exclusive access to future government awards or utility contracts.

What do Centrus Energy’s latest financial results reveal about the cost of rebuilding enrichment capacity?

Centrus Energy entered the expansion phase with an established nuclear fuel supply business, but its second-quarter financial performance showed the difference between revenue growth and earnings growth.

Revenue increased 14% year on year to $176.1 million during the quarter ended June 30, 2026, compared with $154.5 million in the corresponding period of 2025. GAAP net income declined approximately 42% to $16.8 million from $28.9 million, reflecting higher expenses and changes in operating performance.

Adjusted net income increased to $38.7 million from $34.5 million, highlighting a difference between the company’s reported and non-GAAP earnings measures. Investors assessing the expansion must distinguish between operating performance and adjustments affecting the earnings presentation.

The company’s low-enriched uranium segment generated $153.4 million in second-quarter revenue, an increase of approximately 22% year on year. Technical Solutions revenue declined to $22.7 million from $28.8 million, demonstrating that business segments can experience different performance trajectories during the same reporting period.

At June 30, Centrus Energy reported approximately $1.87 billion in cash and cash equivalents, alongside approximately $1.18 billion in long-term debt. These figures predate the subsequent September financing and October acquisition and should not be interpreted as the company’s current cash position.

The group reported $94.8 million in capital expenditure during the first six months of 2026, compared with $5.7 million a year earlier. Management’s August guidance called for total capital deployment of $350 million to $500 million during 2026, reflecting the increasing financial demands of the industrial expansion.

The difference between current earnings and future investment requirements creates a substantial capital-allocation challenge. Manufacturing and infrastructure expenditure must be incurred before the new enrichment capacity begins contributing meaningfully to commercial output.

The next financial report will provide updated information on cash deployment, acquisition effects and construction expenditure following the September fundraising.

How does Centrus Energy’s $500 million equity offering affect the funding and dilution outlook?

Centrus Energy completed a substantial capital markets transaction in September 2026 to support its wider corporate and expansion requirements. The financing included approximately $500 million of common equity and pre-funded warrant consideration, accompanied by additional common warrants.

The offering comprised 500,000 Class A common shares and pre-funded warrants covering approximately 2.01 million additional shares. Investors also received common warrants covering up to approximately 6.99 million shares.

The common warrants have exercise prices ranging from approximately $226.86 to $362.98 per share, depending on the series. Their potential aggregate exercise proceeds are substantial, but those proceeds would arise only if the relevant warrants were exercised.

Accordingly, the offering’s initial funding should not be combined with all potential warrant proceeds as though the entire amount had already been received. Similarly, the full number of common-warrant shares should not automatically be treated as outstanding ordinary shares.

The transaction provides additional financial resources during an unusually capital-intensive period. It also introduces potential future dilution associated with the warrant structure, subject to exercise.

For shareholders, the relevant financial assessment is whether the capital raised can support expansion projects that eventually generate returns exceeding their funding and operating costs. The financing improves Centrus Energy’s flexibility but does not eliminate the need for effective project execution.

The stock’s subsequent decline has also made the warrant exercise thresholds an important consideration. With shares trading substantially below the lowest common-warrant exercise price at the October 29 close, exercise of those warrants would not currently provide an economically straightforward funding source for holders seeking immediate value. Future proceeds depend on subsequent market prices, holder decisions and the contractual terms.

Centrus Energy’s $4.5 billion backlog contains different levels of revenue certainty

The company’s reported backlog provides evidence of customer demand but requires careful interpretation. At June 30, 2026, Centrus Energy reported approximately $4.5 billion in total backlog across its operating segments, extending through 2040.

The low-enriched uranium segment accounted for approximately $3.7 billion of that amount. The company also disclosed approximately $3 billion in contingent low-enriched uranium and HALEU sales commitments associated with potential capacity expansion, including approximately $2.4 billion under definitive agreements.

These contingent commitments are linked to future operational milestones and should not be treated as fully unconditional revenue. Their realisation depends partly on Centrus Energy delivering the required enrichment capacity and satisfying relevant contractual conditions.

Technical Solutions backlog was approximately $800 million at June 30, including funded work, unfunded amounts and unexercised options. The company disclosed that the proposed federal budget for fiscal 2027 did not include additional funding for the previous HALEU operation contract, while the Department of Energy had indicated that it did not then intend to exercise further options under that arrangement.

This earlier contract should be distinguished from the newer $900 million HALEU production agreement supporting capacity deployment. The two relate to different contractual arrangements and stages of the company’s enrichment programme.

Backlog quality therefore depends on the proportion supported by firm customer obligations, available funding and achievable production milestones. A larger reported pipeline can strengthen revenue visibility, but conditional commitments will only become commercially meaningful as the underlying requirements are satisfied.

Why did Centrus Energy stock fall despite the early centrifuge manufacturing milestone?

Centrus Energy shares closed at $110.55 on October 29, 2026, down 1.27% from the previous session’s closing price of $111.97. The shares traded between $109.43 and $116.61 during the session, indicating a relatively broad intraday range.

The stock was also trading considerably below its reported 52-week high of approximately $402, representing a decline of around 72.5% from that level. Its 52-week low stood at approximately $96.80, placing the October 29 close about 14.2% above that low.

The share-price history demonstrates that investor expectations around Centrus Energy have changed considerably during 2026. However, the October 29 decline should not be attributed exclusively to the centrifuge announcement because broader market conditions, valuation considerations and company-specific factors can influence daily trading.

The stock’s recovery from its October 26 closing price of $98.44 also shows that short-term performance has been volatile. The October 29 close remained approximately 12.3% above that earlier closing price despite the latest daily decline.

The company’s market value was approximately $2.26 billion at the October 29 close, based on reported share information and market pricing. Its valuation reflects an operating nuclear fuel business alongside expectations for future domestic enrichment capacity.

The principal investment tension involves timing. Centrus Energy is making significant manufacturing progress and has secured substantial government and customer commitments, but its planned new enrichment capacity remains several years from initial operation.

A more durable improvement in investor confidence would likely require evidence that manufacturing progress is translating into predictable construction milestones, manageable capital spending and credible future operating economics.

November 4 earnings will test Centrus Energy’s financial position before the 2029 production target

Centrus Energy is scheduled to report third-quarter 2026 earnings after US markets close on November 4, followed by a conference call on November 5 at 8:30 a.m. Eastern Time. The update will provide the first comprehensive quarterly financial report following the company’s September financing and will precede full-quarter financial reporting of the October Westerman acquisition.

Investors will be able to assess updated liquidity, capital deployment and management’s expectations for the remainder of 2026. Any additional information about manufacturing throughput, supplier readiness and construction progress could also clarify how the expansion is developing relative to its timetable.

The near-term operating test involves increasing centrifuge manufacturing rates without compromising equipment quality or creating substantial cost overruns. Further milestones will involve installation and commissioning in Ohio, followed by the start of additional enrichment capacity in 2029.

Centrus Energy has moved beyond a purely prospective expansion strategy by completing its first newly manufactured centrifuge and establishing a larger domestic supply network. Its government contract, customer commitments and recent financing provide several sources of support for the programme, but they do not eliminate execution requirements.

The most important evidence over the next year will be whether the company can translate its first completed machine into repeatable industrial production while keeping capital expenditure consistent with available funding. Progress towards installed enrichment capacity, rather than centrifuge shipment announcements alone, will determine whether the strategy creates a sustainable addition to America’s nuclear fuel supply.

Key takeaways from Centrus Energy’s Ohio centrifuge expansion and LEU stock outlook

• Centrus Energy began shipping newly manufactured centrifuges from Oak Ridge, Tennessee, to Ohio on October 29, 2026, ahead of its year-end manufacturing target.
• The milestone supports a multibillion-dollar uranium enrichment expansion, with additional capacity currently expected to begin operations in 2029.
• A previously announced $560 million investment is intended to expand the Oak Ridge facility’s ability to manufacture advanced centrifuges at scale.
• The recent $116 million acquisition of Westerman Holdings adds an established supplier of critical centrifuge components to Centrus Energy’s manufacturing operations.
• The company has a $900 million Department of Energy contract supporting commercial-scale HALEU capacity development, with additional optional funding tied to future deliveries.
• Centrus Energy reported second-quarter revenue growth of 14%, although GAAP net income declined approximately 42% year on year.
• The September $500 million equity and pre-funded warrant financing provides capital for corporate requirements, while additional common-warrant proceeds remain conditional.
• Reported backlog includes contingent customer commitments, meaning the full amount should not be interpreted as unconditional future revenue.
• Centrus Energy stock closed at $110.55 on October 29, approximately 72.5% below its reported 52-week high.
• The November 4 earnings report and subsequent manufacturing milestones will provide updated evidence of the expansion’s financial and operational progress.